Genolution Inc. (225220) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.013x

Based on the latest financial reports, Genolution Inc. (225220) has a cash flow conversion efficiency ratio of -0.013x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-927.21 Million ≈ $-628.35K USD) by net assets (₩73.39 Billion ≈ $49.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Genolution Inc. for the company's overall valuation and market capitalisation.

Genolution Inc. - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Genolution Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Genolution Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Genolution Inc. ranked by their cash flow conversion efficiency. Explore 225220 cash flow quality score to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
O.C.C. Public Company Limited BK:OCC	-0.033x
Clime Investment Management Ltd AU:CIW	-0.055x
NORTHERN FREEGOLD F:8N6	-0.086x
KONG SUN (BL25000) F:KOJ5	N/A
Bright Scholar Education Holdings Ltd Class A NYSE:BEDU	-0.021x
Worldwide Healthcare Trust Plc LSE:WWH	-0.002x
Archos PA:ALJXR	0.150x
Hands Corporation Ltd KO:143210	0.069x

Annual Cash Flow Conversion Efficiency for Genolution Inc. (2016–2024)

The table below shows the annual cash flow conversion efficiency of Genolution Inc. from 2016 to 2024. View Genolution Inc. (225220) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩80.29 Billion ≈ $54.41 Million	₩-1.43 Billion ≈ $-970.93K	-0.018x	-37.43%
2023-12-31	₩87.45 Billion ≈ $59.26 Million	₩-1.14 Billion ≈ $-769.54K	-0.013x	-109.07%
2022-12-31	₩94.70 Billion ≈ $64.18 Million	₩13.55 Billion ≈ $9.18 Million	0.143x	-54.29%
2021-12-31	₩82.20 Billion ≈ $55.71 Million	₩25.73 Billion ≈ $17.44 Million	0.313x	-58.26%
2020-12-31	₩61.29 Billion ≈ $41.54 Million	₩45.97 Billion ≈ $31.15 Million	0.750x	+2556.06%
2019-12-31	₩2.64 Billion ≈ $1.79 Million	₩-80.58 Million ≈ $-54.61K	-0.031x	-160.85%
2018-12-31	₩2.94 Billion ≈ $1.99 Million	₩147.49 Million ≈ $99.95K	0.050x	-72.00%
2017-12-31	₩4.00 Billion ≈ $2.71 Million	₩717.13 Million ≈ $485.99K	0.179x	+2372.91%
2016-12-31	₩3.42 Billion ≈ $2.32 Million	₩-27.00 Million ≈ $-18.30K	-0.008x	--

About Genolution Inc.

KQ:225220 Korea Biotechnology

Market Cap

$17.48 Million

₩25.80 Billion KRW

Market Cap Rank

#25629 Global

#1906 in Korea

Share Price

₩1428.00

Change (1 day)

-0.07%

52-Week Range

₩1030.00 - ₩2410.00

All Time High

₩10300.23